Presentation CTO 2026 Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization Presenter: Nayana Bhandari February 14, 2026 REGISTER for free or LOG IN to view this content CTO 2026 Up Next Presentation CTO 2026 Artificial‑Intelligence–Derived Quantitative Analyses of Plaque Composition in Patients Undergoing CTO PCI: From PROGRESS‑CTO Registry Presenter: Pedro Carvalho February 14, 2026 More slides + Presentation CTO 2026 Paclitaxel or Sirolimus Coated Balloon After Recanalization of Chronic Total Occlusion: A Subanalysis of the PICCOLETO X Multicenter Study Presenter: Bernardo Cortese February 14, 2026 Presentation CTO 2026 One Collateral, Two CTOs: Sequential Retrograde Recanalization of LAD and RCA CTOs Using a Shared Septal Collateral Network Presenter: Omar Sami Abdelhai February 14, 2026 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation CTO 2026 Artificial‑Intelligence–Derived Quantitative Analyses of Plaque Composition in Patients Undergoing CTO PCI: From PROGRESS‑CTO Registry Presenter: Pedro Carvalho February 14, 2026
Presentation CTO 2026 Paclitaxel or Sirolimus Coated Balloon After Recanalization of Chronic Total Occlusion: A Subanalysis of the PICCOLETO X Multicenter Study Presenter: Bernardo Cortese February 14, 2026
Presentation CTO 2026 One Collateral, Two CTOs: Sequential Retrograde Recanalization of LAD and RCA CTOs Using a Shared Septal Collateral Network Presenter: Omar Sami Abdelhai February 14, 2026